Press Release August 3, 2021Regeneron Announces the 2021 Winners of the Regeneron Prize for Creative Innovation 0 0 Share
Company Ticker News August 2, 2021FDA Approves Regeneron - Roche's COVID-19 Antibody Cocktail For Post-Exposure Prophylaxis 0 0 Share
Press Release July 29, 2021Regeneron - Sanofi's Dupixent Improves Itch, Hives In Inflammatory Skin Disease Patients 0 0 Share
Press Release July 29, 2021Dupixent® (dupilumab) Significantly Improved Itch and Hives in Patients with Chronic Spontaneous Urticaria, a Step Forward in Demonstrating the Role of Type 2 Inflammation in These Patients 0 0 Share
Press Release July 29, 2021Dupixent® (dupilumab) significantly improved itch and hives in patients with chronic spontaneous urticaria, a step forward in demonstrating the role of type 2 inflammation in these patients 0 0 Share
Press Release July 27, 2021Regeneron and AstraZeneca to Research, Develop and Commercialize New Small Molecule Medicines for Obesity 0 0 Share
Press Release July 20, 2021Japan Becomes First Country to Approve Regeneron Antibody Cocktail (casirivimab and imdevimab) for the Treatment of Mild to Moderate COVID-19 0 0 Share
Company Ticker News July 15, 2021This 1 Medical Stock Could Beat Earnings: Why It Should Be on Your Radar 0 0 Share